Clinical Trial Update: A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 exploratory trial is evaluating enlansibumab sequentially with concurrent chemoradiotherapy for locally advanced cervical cancer; the study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Enlansibumab (Enlansibumab)

Snippet

Sponsor: Chongqing University Cancer Hospital | Conditions: LOCALLY ADVANCED CERVICAL CANCERS | Phase 2 | Status: NOT_YET_RECRUITING